PharmaShots | Incisive News in 3 Shots

Subscribe Now

Ensem Therapeutic EXT-197

BeiGene Acquires an Exclusive Global License from Ensem Therapeutics for its Experimental Oral CDK2 Inhibitor EXT-197

BeiGene Acquires an Exclusive Global License from Ensem Therapeutics for its Experimental Oral CDK2 Inhibitor EXT-197

November 22, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us